Canakinumab

Details

Files

Generic Name:

Canakinumab

Project Status:

Complete

Therapeutic Area:

Cryopyrin-Associated Periodic Syndrome

Manufacturer:

Novartis Pharmaceuticals Canada Inc.

Call for patient/clinician input open:

June 30, 2010

Brand Name:

Ilaris

Project Line:

Reimbursement Review

Project Number:

SR0204-000

Call for patient/clinician input closed:

July 28, 2010

NOC Status at Filing:

Post NOC

Submission Type:

Initial

Indications:

Cryopyrin-Associated Periodic Syndrome (CAPS)

Recommendation Type:

Do not list

Final Recommendation:

January 26, 2011

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Plain Language Recommendation View PDF

Last Updated : July 7, 2010